✉ Email this page to a colleague
« Back to Dashboard
Meso-Erythritol is an investigational drug.
There have been 22 clinical trials for Meso-Erythritol. The most recent clinical trial was a Phase 2 trial, which was initiated on June 1st 2018.
The most common disease conditions in clinical trials are Mesothelioma, Malignant, Mesothelioma, and Pancreatic Neoplasms. The leading clinical trial sponsors are Stony Brook University, Hrain Biotechnology Co., Ltd., and Hrain Biotechnology Co.,Ltd.
There are fifteen US patents protecting this investigational drug and five hundred and twenty-seven international patents.
Recent Clinical Trials for Meso-Erythritol
|Efficacy of Sunlight Activated Synthetic Porphyrin in COVID-19 Infected Patients||Kafrelsheikh University||Phase 1|
|Evaluation of the Implementation and Effectiveness of Intermittent Preventive Treatment for Malaria Using Dihydroartemisinin-piperaquine on Reducing Malaria Burden in School Aged Children in Tanzania||National Malaria Control Program, Tanzania||Phase 4|
|Evaluation of the Implementation and Effectiveness of Intermittent Preventive Treatment for Malaria Using Dihydroartemisinin-piperaquine on Reducing Malaria Burden in School Aged Children in Tanzania||National Institute for Medical Research, Tanzania||Phase 4|
Top disease conditions for Meso-Erythritol
Top clinical trial sponsors for Meso-Erythritol
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Meso-Erythritol||⤷ Try a Trial||Composition for relieving subjective symptoms of fatigue||Kyowa Hakko Bio Co., Ltd. (Tokyo, JP)||⤷ Try a Trial|
|Meso-Erythritol||⤷ Try a Trial||Methods for the electrolytic production of erythrose or erythritol||Dynamic Food Ingredients Corporation (Kirkland, WA)||⤷ Try a Trial|
|Meso-Erythritol||⤷ Try a Trial||High-potency sweetener composition with rubisco protein, rubiscolin, rubiscolin derivatives, ace inhibitory peptides, and combinations thereof, and compositions sweetened therewith||The Coca-Cola Company (Atlanta, GA)||⤷ Try a Trial|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|Meso-Erythritol||Australia||AU8494291||2010-08-31||⤷ Try a Trial|
|Meso-Erythritol||Canada||CA2090620||2010-08-31||⤷ Try a Trial|
|Meso-Erythritol||European Patent Office||EP0548138||2010-08-31||⤷ Try a Trial|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|